Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against XEC Centers for Disease Control reports XEC and KP.3.1.1 (previously disclosed as sus ...

The following is a summary of “Four COVID-19 screening strategies for early case identification within the homeless shelter ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

By Dr. Liji Thomas, MD Study reveals how the JAK inhibitor lowers ACE2 expression and viral entry in individuals with a ...

The National Institute of Mental Health has awarded a significant grant of $1.5 million to Jianyang Du, PhD, of the ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.